Interestingly, in our NASH/NAFLD patients, serum VEGF-A levels positively correlate with the fibrosis stage and grade as well, confirming a role of this major angiogenic factor in the pathogenesis of NASH. The gene discussed is VEGFA; the disease is metabolic dysfunction-associated steatohepatitis.